Lifeboat Foundation

The next big event on the tech show calendar is almost upon us. The CES 2021 kicks off on Monday, 11^th January and runs for four days. Last year it was held just ahead of the Covid-19 pandemic wave, so ended up being one of the last physical exhibitions covered by the tech press. This year it will be somewhat reduced and virtual only. However the organisers, the Consumer Technology Association (CTA), have already been booking venues for 2022 having faith in the various vaccines being able to provide enough personal safety for a hybrid event.

In 2020 the CES show attracted 171268 attendees, including 6517 members of the media, to promotional venues stuffed by 4400 exhibitors. In 2021 expect these numbers to be scaled down. We do have important keynotes and presentations from the likes of AMD, Nvidia, and Samsung to look forward to but the online-only event will feature a relatively small 1000 exhibitors. Being online will open up ‘attendance’ more widely though, with almost the same number of fold expected to take part in the show this year as last (estimated to be 150000 visitors in 2021).

Before the century is out, advances in nanotechnology, nanomedicine, AI, and computation will result in the development of a “Human Brain/Cloud Interface” (B/CI), that connects neurons and synapses in the brain to vast cloud-computing networks in real time.

That’s the prediction of a large international team of neurosurgeons, roboticists, and nanotechnologists, writing in the journal Frontiers in Neuroscience.

A Human Brain/Cloud Interface, sometimes dubbed the “internet of thoughts”, theoretically links brains and cloud-based data storage through the intercession of nanobots positioned at strategically useful neuronal junctions.

Biochemists use protein engineering to transfer photocaging groups to DNA.

DNA (deoxyribonucleic acid) is the basis of life on earth. The function of DNA is to store all the genetic information, which an organism needs to develop, function and reproduce. It is essentially a biological instruction manual found in every cell.

Biochemists at the University of Münster have now developed a strategy for controlling the biological functions of DNA with the aid of light. This enables researchers to better understand and control the different processes which take place in the cell – for example epigenetics, the key chemical change and regulatory lever in DNA.

Scientists from Russia and Switzerland have probed into nanostructures covering the corneas of the eyes of small fruit flies. Investigating them the team learned how to produce the safe biodegradable nanocoating with antimicrobial, anti-reflective, and self-cleaning properties in a cost-effective and eco-friendly way. The protection coating might find applications in diverse areas of economics including medicine, nanoelectronics, automotive industry, and textile industry. The article describing these discoveries appears in Nature.

Scientists from Far Eastern Federal University (FEFU, Russia) teamed up with colleagues from University of Geneva, The University of Lausanne, and Swiss Federal Institute of Technology in Zurich for an interdisciplinary research project during which they were able to artificially reproduce the nanocoating of the corneas of fruit flies (Drosophila flies) naturally designed to protect the eyes of the insects from the smallest dust particles and shut off the reflection of light.

The craft of nanocoating meets demands in various fields of economics. It can wrap up any flat or three-dimensional structure, and, depending on the task, give it anti-reflective, antibacterial, and hydrophobic properties, including self-cleaning. The latter, for example, is a very important feature for expensive reusable overnight ortho-k lenses that correct the eyesight. Similar anti-reflective coatings are already known though created by more complex and costly methods. They are being used on the panels of computers, glasses, paintings in museums can be covered with them in order to exclude reflection and refraction of light.

Ralph Baric, PhD, is the William R. Kenan, Jr. Distinguished Professor in the Department of Epidemiology and Professor in the Department of Microbiology and Immunology. He is a Harvey Weaver Scholar from the National Multiple Sclerosis Society and an Established Investigator Awardee from the American Heart Association. In addition, he is a World Technology Award Finalist and a fellow of the American Association for Microbiology. He has spent the past three decades as a world leader in the study of coronaviruses and is responsible for UNC-Chapel Hill’s world leadership in coronavirus research. For these past three decades, Dr. Baric has warned that the emerging coronaviruses represent a significant and ongoing global health threat, particularly because they can jump, without warning, from animals into the human population, and they tend to spread rapidly.

The Baric Lab uses coronaviruses as models to study the genetics of RNA virus transcription, replication, persistence, pathogenesis, genetics and cross-species transmission. He has used alphavirus vaccine vectors to develop novel candidate vaccines. Dr. Baric has led the world in recognizing the importance of zoonotic viruses as a potentially rich source of new emerging pathogens in humans, with detailed studies of the molecular, genetic and evolutionary mechanisms that regulate the establishment and dissemination of such a virus within a newly adopted host. Specifically, he works to decipher the complex interactions between the virion and cell surface molecules that function in the entry and cross-species transmission of positive-strand RNA viruses.

Continue reading “Ralph S. Baric, PhD” »

Some 21 residents of a Bat Yam retirement home tested positive for the coronavirus after they were vaccinated but before they had developed antibodies, according to Ynet.

The other 150 residents of the home will be tested for the virus.

Health officials have stressed that the two-dose Pfizer vaccine regimen means that the vaccine is only fully effective about five weeks after the first dose. This means it could take until sometime in February for enough elderly and high-risk people to be vaccinated to help lower the spread of infection and start reopening the economy.

Continue reading “21 Residents of Retirement Home Get Coronavirus After Receiving Vaccine” »

#JustAReminder why knowing the origin of this disease is so important. Shi Zhengli who ran the lab in Wuhan worked with Ralph Baric on this gain of function research.

Declan Butler.

12 November 2015

Continue reading “Engineered bat virus stirs debate over risky research” »

MEXICO CITY (Reuters) — Mexican authorities said they are studying the case of a 32-year-old female doctor who was hospitalized after receiving the Pfizer-BioNTech COVID-19 vaccine.

The doctor, whose name has not been released, was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing and a skin rash.

“The initial diagnosis is encephalomyelitis,” the Health Ministry said in a statement released on Friday night. Encephalomyelitis is an inflammation of the brain and spinal cord.

ISRIB, a new drug that reboots protein production in cells can reverse aging declines in memory and cognition in mice, with no side effects.